SECORIM® ABO

Fighting the world’s organ shortage

SECORIM®-ABO enables transplantations across blood group barriers by specific removal of the organ recipient’s blood group anti-A and/or anti-B antibodies (ABO-antibodies).

Fighting the world’s organ shortage

SECORIM®-ABO has its potential in living-donor kidney transplantation with further use for other transplantations, such as liver, heart, lung, bone marrow and stem cells. Clinical results and data of transplantations performed after specific removal of incompatible ABO-antibodies by immunoadsorption in combination with immunosuppression report successful clinical outcomes similar to those of ABO compatible kidney transplantation, both short and long-term.

Selective immunoadsorption treatment, potentially increases the number of transplantations from living donors.

TRANSPLANTATION ACROSS BLOOD BARRIERS

Specific removal of A and B antibodies, offering substantial advantage over other methods

The SECORIM®-ABO employs synthetic carbohydrate antigens immobilized on porous polymer beads to exclusively reduce the number of ABO-antibodies.

The specific removal of antibodies by SECORIM®-ABO prohibit several side effects compared to other pretreatment methods, e.g. plasma exchange. Specific antibody removal retains many valuable physiological plasma components.
Therefore, SECORIM®-ABO offers a substantial advantage compared to other methods.

Scheme of Treatment

The Immunoadsorption process takes places in an extracorporeal circuit where the blood plasma is separated from other blood components prior to enter the VitroSorb SECORIM® column.

SECORIM® ABO facilitates ABO-incompatible transplantations through reduction of blood group A or B antibodies, and thereby enables transplantation across blood group barriers by specific removal of the organ recipient’s blood group Antibodies.

Video

Watch how the procedure works and how SECORIM® assists during organ transplantation.

Want to know more?

Want to know more about our product or distributor locations? Get in touch with us, and we will get back to you.

SECORIM® ABO

Fighting the world’s organ shortage

SECORIM®-ABO enables transplantations across blood group barriers by specific removal of the organ recipient’s blood group anti-A and/or anti-B antibodies (ABO-antibodies).

Fighting the world’s organ shortage

SECORIM®-ABO has its potential in living-donor kidney transplantation with further use for other transplantations, such as liver, heart, lung, bone marrow and stem cells. Clinical results and data of transplantations performed after specific removal of incompatible ABO-antibodies by immunoadsorption in combination with immunosuppression report successful clinical outcomes similar to those of ABO compatible kidney transplantation, both short and long-term.

Selective immunoadsorption treatment, potentially increases the number of transplantations from living donors.

Secorim

TRANSPLANTATION ACROSS BLOOD BARRIERS

Specific removal of A and B antibodies, offering substantial advantage over other methods

The SECORIM®-ABO employs synthetic carbohydrate antigens immobilized on porous polymer beads to exclusively reduce the number of ABO-antibodies.

The specific removal of antibodies by SECORIM®-ABO prohibit several side effects compared to other pretreatment methods, e.g. plasma exchange. Specific antibody removal retains many valuable physiological plasma components.
Therefore, SECORIM®-ABO offers a substantial advantage compared to other methods.

SECORIM Transplantation across bloodbarriers

Scheme of Treatment

The Immunoadsorption process takes places in an extracorporeal circuit where the blood plasma is separated from other blood components prior to enter the VitroSorb SECORIM® column.

SECORIM® ABO facilitates ABO-incompatible transplantations through reduction of blood group A or B antibodies, and thereby enables transplantation across blood group barriers by specific removal of the organ recipient’s blood group Antibodies.

Immunoadsorption

Video

Watch how the procedure works and how SECORIM® assists during organ transplantation.

Want to know more?

Want to know more about our product or distributor locations? Get in touch with us, and we will get back to you.

This website uses cookies. By continuing to use this site, you accept our use of cookies.  Learn more